Elsevier

Early Human Development

Volume 30, Issue 3, October 1992, Pages 241-248
Early Human Development

Effect of morphine and pancuronium on the stress response in ventilated preterm infants

https://doi.org/10.1016/0378-3782(92)90073-PGet rights and content

Abstract

Nintey-five premature newborns who had hyaline membrane disease and were struggling against the ventilator were randomised to one of three treatment groups: morphine (group M), pancuronium (group P) or morphine with pancuronium (group M+P). The dose of morphine was 50 μg/kg per h but was increased to 100 μg/kg per h in group M infants if they continued to struggle. The dosage of pancuronium was 100 μg/kg given as required to inhibit spontaneous respiration. Plasma catecholamine levels were measured on entry and at 24 h. Blood pressure and ventilatory requirements were determined on entry and at 6 h. The clinical outcome of the infants was documented. Group M infants (n=29) showed a significant reduction in noradrenaline levels (median change −2.2 nmols/1 (range −47.2 to +7.2 nmols/1), although seven were withdrawn from this group because of failure to settle. Group P (n=28) and group M + P (n=38) showed no significant change in noradrenaline levels. Comparison between the groups showed that group M infants had a significant reduction in noradrenaline levels compared with group P. The immediate effects of treatment on blood pressure and ventilatory requirements were similar in the three groups. The clinical outcome did not differ for any of the measured parameters. When adequate sedation is achieved, morphine may reduce the stress of newborn intensive care.

References (17)

There are more references available in the full text version of this article.

Cited by (58)

  • Evaluations of Morphine and Fentanyl for Mechanically Ventilated Patients With Respiratory Disorders in Intensive Care: A Systematic Review of Methodological Trends and Reporting Quality

    2019, Value in Health Regional Issues
    Citation Excerpt :

    In the remaining 2 studies, the behavioral state of the neonates determined the outcome of sedation, with lower scores reflecting better sedated neonates.19,27 One study measured the duration of MV and mortality as other primary, but undefined, outcomes.29 Another primary outcome, neurodevelopmental function, measured cognitive and language function using the mental development index and gross motor development using the psychomotor development index.36

  • Clinical and Economic Analysis of Morphine Versus Fentanyl in Managing Ventilated Neonates With Respiratory Distress Syndrome in the Intensive Care Setting

    2019, Clinical Therapeutics
    Citation Excerpt :

    Referring to the RCT by Anand et al,19 however, the mortality rate was found to be comparable based on similar durations of analgesia between study groups.9 In Quinn et al,45 mortality among study groups, although not clearly defined, did not differ when followed, based on equal groups’ durations of therapy. Hence, the increased mortality with morphine in this study can be attributed to the large difference in the duration of analgesia observed (12 days with morphine over fentanyl).

  • Sedation and analgesia to facilitate mechanical ventilation

    2013, Clinics in Perinatology
    Citation Excerpt :

    Among the first to suggest clinical benefit, the NOPAIN trial reported decreased rates of periventricular leukomalacia, severe IVH, and death when morphine was prophylactically infused into mechanically ventilated premature neonates.65 Other small, randomized controlled trials reported improved ventilator synchrony and serum stress markers in response to morphine.28,29,111 In contrast, 2 large, placebo-controlled trials could not demonstrate the benefit of morphine for intubated neonates found in smaller trials.

  • Does neonatal morphine use affect neuropsychological outcomes at 8 to 9 years of age?

    2013, Pain
    Citation Excerpt :

    Follow-up of randomized controlled trials (RCT) helps to evaluate the effect of morphine on long-term outcomes. More than a decade ago, the first follow-up study [46] of 2 RCTs [53,54] in preterm infants on morphine, pancuronium, and placebo found no effect of neonatal morphine use on intelligence, visual motor integration, or behavior 5 to 6 years later. In a small pilot follow-up in 5- to 7-year-old children who had been mechanically ventilated after birth, those who had received morphine (n = 14) had comparable intelligence quotient (IQ) scores and academic achievements to those who had received placebo (n = 5).

  • A pilot study of preemptive morphine analgesia in preterm neonates: Effects on head circumference, social behavior, and response latencies in early childhood

    2012, Neurotoxicology and Teratology
    Citation Excerpt :

    Given the long-term neurological impact of untreated neonatal pain (Fitzgerald and Walker, 2009), it is essential to determine the long-term effects of preemptive analgesia. Several randomized trials have begun to evaluate the efficacy of preemptive analgesia in neonates; specifically, opiate and sedative treatment (e.g., Anand et al., 2004; Quinn et al., 1992, 1993; Roze et al., 2008). Three have described long-term outcomes of such analgesia (de Graaf et al., 2011; MacGregor et al., 1998; Roze et al., 2008).

  • Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: Five-year follow-up of a randomized controlled trial

    2011, Pain
    Citation Excerpt :

    The one comparable previous study did not find adverse effects of neonatal morphine on the intelligence, motor function, and behavior of 5- to 6-year-old children [29]. This study differed from the present study with regard to the 5- to 10-fold higher morphine dosage, the induction of neuromuscular paralysis, and lack of an observational and validated pain assessment instrument [36,37]. A limitation of the MacGregor [29] study was that only overall IQ, overall motor ability, and overall behavior were analyzed.

View all citing articles on Scopus
View full text